How to Help Your Patients Find Tri-Lo-Mili in Stock: A Provider's Guide

When a patient can't fill their birth control, the clock is ticking. Tri-Lo-Mili availability issues — while not a formal FDA shortage — generate a significant volume of patient calls, portal messages, and prescription change requests. This guide gives you a clear, efficient workflow to resolve these issues quickly and protect your patients' contraceptive continuity.

Understanding Why Your Patients Are Having Trouble

The core issue: Tri-Lo-Mili (Aurobindo) is one of several generic equivalents of the discontinued brand-name Ortho Tri-Cyclen Lo. Pharmacy chains have preferred supplier contracts with different generic manufacturers — so a pharmacy that stocks Tri-Lo-Sprintec may not carry Tri-Lo-Mili at all, or may only stock it intermittently. Patients whose insurance formulary lists Tri-Lo-Mili specifically may not be automatically covered if they receive a different generic, even though the medications are therapeutically identical.

This creates a friction point between formulary coverage and pharmacy inventory that patients experience as a "shortage" — even when the drug class is not in a formal supply crisis.

Step-by-Step: How to Handle a Tri-Lo-Mili Availability Request

Assess urgency: Ask the patient how many pills they have remaining. If they have fewer than 7 active pills left, treat this as urgent and prioritize same-day resolution.

Check for clinical contraindications to alternatives: For most patients, switching to any other norgestimate/EE 0.025 mg triphasic generic is clinically equivalent. Flag cases where estrogen dose increase might be contraindicated (migraines with aura, hypertension, cardiovascular risk).

Update the prescription to generic name: Send an updated e-prescription for "norgestimate/ethinyl estradiol 0.18/0.215/0.25 mg-0.025 mg, 28-tab dispense pack, may substitute" to a pharmacy that has confirmed stock. This one change often resolves the issue immediately.

Help the patient find a pharmacy with stock: Instruct your care coordinator or medical assistant to direct the patient to medfinder, which calls pharmacies near the patient to locate stock. This eliminates the back-and-forth of the patient calling multiple pharmacies.

Address the insurance side if needed: If the patient's insurer requires PA for a generic switch, submit a brief formulary exception citing the availability issue and clinical equivalence. Most plans have streamlined this for the norgestimate/EE class.

Recommended Generic Substitutes by Availability Tier

Use this hierarchy when Tri-Lo-Mili is unavailable:

First choice: Any other norgestimate/EE 0.025 mg triphasic generic (Tri-Lo-Sprintec, Tri-Lo-Estarylla, Tri-Lo-Marzia, Tri-VyLibra Lo) — therapeutically equivalent, same dose.

Second choice (if 0.025 mg EE unavailable): Norgestimate/EE 0.035 mg triphasic generic (Tri-Sprintec, Tri-Mili, Tri-Estarylla, Tri-Linyah) — same progestin, slightly higher estrogen dose. Appropriate for most patients without EE-sensitive conditions.

Third choice: Different progestin low-estrogen COC (e.g., drospirenone/EE, levonorgestrel/EE) — appropriate for patients who need a low-estrogen option but cannot access norgestimate/EE equivalents.

For estrogen-intolerant patients: Progestin-only pills, IUD, or implant.

Patient Communication Templates

Here are brief scripts your team can use for portal messages or calls:

When switching to an equivalent generic: "We have updated your prescription to Tri-Lo-Sprintec, which contains the same active hormones as Tri-Lo-Mili at the same doses. Only the manufacturer is different. You do not need to restart your pack or use backup contraception if you have not missed any active pills. Please let us know if you have any questions."

When directing patient to locate a pharmacy: "We've updated your prescription so that any norgestimate/EE 0.025 mg triphasic generic can be dispensed. To find a pharmacy near you with it in stock, we recommend using medfinder.com, which calls local pharmacies on your behalf. If you are running low on pills, please contact us immediately so we can prioritize resolution."

Proactive Strategies to Reduce Future Availability Calls

Always prescribe by generic name rather than a specific branded generic, with "may substitute" language.

Offer 90-day or 12-month supplies to reduce refill frequency and availability windows.

Consider routing to mail-order pharmacies for patients in rural or underserved areas with limited pharmacy options.

Discuss LARC options with patients who repeatedly face access difficulties or who express concern about ongoing refill challenges.

For a provider-focused overview of the medfinder service, visit medfinder for providers.